CARL vs JPM · rev $50.5M vs P/E 14, rev $57.35B
Carlsmed, Inc. Common Stock (CARL) versus JPMorgan Chase & Co (JPM) — a side-by-side from cached financials, not a winner call.
Carlsmed, Inc. Common Stock (CARL) is a health information services company listed on NASDAQ.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Latest reported CARL revenue for 2025-12-31 was $50.5M. Net income was -$29.6M. Revenue was up 85.9% from 2024-12-31 to 2025-12-31. CARL currently screens at market cap $299.7M.
Latest reported JPM revenue for 2026-06-30 was $57.35B. Net income was $21.16B. Revenue was up 15.1% from 2026-03-31 to 2026-06-30. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
CARL currently screens at market cap $299.7M. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Not investment advice. Open the CARL and JPM stock pages for the full models.
Not investment advice.